🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — April 26, 2026

These four high-value federal grants totaling $1,907,292,467 obligation are entirely civilian (0/4 defense-related), dominated by Department of Homeland Security (DHS) construction and General Services Administration (GSA) IT services themes. Barnard Construction Company, Incorporated's $1,585,324,926 DHS award represents 83% of the aggregate and carries the highest-conviction bullish signal due to its materiality (8/10). CGI Federal Inc.'s $147,239,431 GSA IT delivery order (base + options $289,432,406) adds another strong bullish signal in computer systems design. Neutral signals from Potomac Electric Power Co ($168,075,608 HHS) and Lockheed Martin Corporation ($6,652,501 GSA) dilute overall momentum (avg strength 5.0/10). Key watch item: zero outlays to date on CGI Federal and Lockheed Martin contracts signal execution ramp-up risks.

4 total filings
· daily

General Federal Contracts — April 26, 2026

This one-day snapshot captures $1,907,292,467 in civilian federal contract obligations across four awards, with zero defense-related activity. Dominant themes are large-scale construction via DHS ($1.59B to Barnard Construction) and IT services via GSA ($147M to CGI Federal and $6.65M to Lockheed Martin), alongside a HHS grant ($168M to Potomac Electric Power). Highest-conviction bullish signals stem from Barnard Construction's $1.59B DHS award and CGI Federal's $147M GSA IT task order (base + options $289M), signaling robust civilian infrastructure and IT demand. Key risk is zero outlays to date on both GSA awards to CGI Federal and Lockheed Martin, with high pricing risk on Lockheed's firm-fixed-price F16 simulator contract.

4 total filings
· daily

Federal Construction & Infrastructure Contracts — April 25, 2026

Three major civilian construction contracts totaling $416,868,972 highlight robust federal infrastructure spending by GSA, DHS Coast Guard, and NIH, with zero defense-related awards. J.E. Dunn Construction Company secured the highest-materiality award at $151,470,288 for FDA laboratory construction, followed by Whiting-Turner Contracting Company's $137,821,964 Coast Guard base recapitalization and Hensel Phelps Construction Co's $127,576,720 NIH building project—all full and open competition firm fixed price wins signaling competitive strength in NAICS 236210/236220. The highest-conviction bullish signal stems from multi-year revenue visibility through 2029 for these non-small business contractors amid stable civilian agency funding. Key risk is high execution/pricing risk across all firm fixed price contracts, particularly with low outlays ($678K for J.E. Dunn, $0 for Whiting-Turner, $36.9M for Hensel Phelps). Investors should watch outlay progression and option exercises for revenue realization.

3 total filings
· daily

Defense Manufacturing Contracts — April 25, 2026

Two DHS Coast Guard contracts totaling $235,798,681 in obligations highlight manufacturing opportunities in aircraft modification and shipbuilding, with a 0/2 defense split indicating purely civilian exposure. The highest materiality award ($83.9M to Birdon America Inc. for Inland Buoy Tender WLR 1801) provides the strongest bullish signal for near-term vessel production growth through 2028. L3Harris Technologies Integrated Systems L.P.'s $151.9M C-130 Minotaur missionization contract offers multi-year revenue visibility into 2024 despite its age. Dominant theme is Coast Guard sustainment of maritime and air assets via full and open competition. Key risk is high pricing risk under firm-fixed-price structures with $0 outlayed to date across both, warranting watches on funding progress.

2 total filings
· daily

DHS Homeland Security Contracts — April 25, 2026

DHS obligated $448,341,387 across 4 civilian contracts (0/4 defense-related) from April 25, 2026 data, dominated by U.S. Coast Guard awards totaling ~$373.6M (83%) for infrastructure recapitalization, vessel construction, and aircraft missionization. Highest-conviction bullish signal is Whiting-Turner Contracting Company's $137.8M firm-fixed price delivery order for Base Seattle CERCLA clean-up and waterfront recapitalization through 2029, supporting Polar Security Cutters homeporting. L3Harris Technologies and Birdon America also secure multi-year Coast Guard revenue streams of $151.9M and $83.9M respectively, while General Dynamics IT's $74.7M USCIS IT contract is neutral and historical. Key risk: $0 outlays across all contracts despite obligations, coupled with high firm-fixed price execution risk on top three awards.

4 total filings
· daily

VA Healthcare & Services Contracts — April 25, 2026

The VA awarded $194,896,742 in healthcare and services contracts during the period, with 0/2 defense-related and all obligations to the civilian Department of Veterans Affairs. Dominant themes center on IT DevSecOps support via a massive $117M obligation to Veterans EZ Info Inc. and short-term medical supplies via $77M to Medline Industries, LP. Highest-conviction bullish signal is Veterans EZ Info's SDVOSB set-aside Delivery Order with $31.7M already outlayed toward a $158M ceiling, offering multi-year revenue visibility to 2030. Key risk is zero outlay on Medline's one-month firm fixed price contract despite its $77.6M obligation, signaling potential execution delays.

2 total filings
· daily

New Federal Contractors — April 25, 2026

This digest covers 11 new federal contracts totaling $1,160,990,335 in obligations, all civilian agency awards with zero defense-related exposure, highlighting steady demand in DHS Coast Guard infrastructure, HHS/NIH construction and IT, and VA services. Dominant themes include multi-year construction wins for Coast Guard recapitalization (e.g., Whiting-Turner $137.8M, Birdon $83.9M) and HHS IT support (Leidos $74.5M + $84.1M), with highest-conviction bullish signals from J.E. Dunn's $151.5M GSA lab construction and Veterans EZ Info's $117.3M VA DevSecOps set-aside, signaling competitive strength in fixed-price civilian builds and IT. Public parents like L3Harris (LHX, $151.9M DHS), Leidos (LDOS, $158.6M total HHS), and General Dynamics (GD, $74.7M DHS) offer direct equity exposure to these revenues. Key risk is pervasive high fixed-price execution risk across top awards amid low initial outlays (e.g., $0 on Whiting-Turner, Birdon), warranting watches on spending progress and option exercises.

11 total filings
· daily

Significant Contract Modifications ($10M+) — April 25, 2026

These 11 significant civilian contract modifications, all under DHS, GSA, HHS, and VA, aggregate $1,160,990,335 in total obligations with zero defense-related awards during April 25-26, 2026. Dominant agency themes center on U.S. Coast Guard (DHS) infrastructure recapitalization and vessel programs ($151.9M L3Harris aircraft missionization, $137.8M Whiting-Turner base cleanup, $83.9M Birdon buoy tender) alongside HHS/NIH construction and IT services. Highest-conviction bullish signals emerge from high-materiality construction wins like J.E. Dunn's $151.5M GSA FDA laboratory (materiality 8/10) and Whiting-Turner's $137.8M DHS delivery order (materiality 8/10), signaling multi-year revenue for industrial builders. Balanced by neutral IT/services awards to Leidos ($158.7M combined HHS obligations). Key risk is pervasive high fixed-price execution risk across 9/11 contracts, with low/no outlays on early-stage awards like Whiting-Turner ($0) and Birdon ($0); watch outlay progression and 2029 performance milestones.

11 total filings
· daily

Contract Deobligations Alert — April 25, 2026

This Contract Deobligations Alert synthesizes 11 civilian agency contracts totaling $1,160,990,335 in obligations, with 0 defense-related awards, highlighting steady execution across construction and IT services amid low average outlays signaling early-stage risks. Dominant themes include DHS Coast Guard infrastructure recapitalization (e.g., Whiting-Turner $137.8M, L3Harris $151.9M) and HHS/VA IT support (e.g., Veterans EZ Info $117.3M, Leidos $74.5M + $84.1M). Highest-conviction bullish signals favor construction primes like J.E. Dunn ($151.5M GSA FDA lab) and Whiting-Turner for multi-year revenue visibility through 2029. Key risk is high fixed-price execution across 9/11 contracts, with minimal outlays (e.g., $0 on several large awards like Birdon America $83.9M). Watch outlay progression and option exercises for revenue recognition clarity.

11 total filings
· daily

Contract Option Exercises — April 25, 2026

These 11 contract option exercises total $1,160,990,335 in obligations, entirely civilian with 0 defense-related awards, highlighting steady federal infrastructure and IT spending outside DOD. Dominant themes include DHS Coast Guard recapitalization ($373.6M across L3Harris $151.9M, Whiting-Turner $137.8M, Birdon $83.9M) and HHS/NIH construction/IT ($366.3M via Hensel Phelps $127.6M, Leidos $158.7M combined). Highest-conviction bullish signal is multi-year Coast Guard infrastructure visibility for L3Harris Technologies and construction peers amid base expansions. VA IT/services add $194.9M via Veterans EZ Info $117.3M and Medline $77.6M. Key risk is pervasive high fixed-price execution across 90%+ of value, with low outlays on several large awards signaling potential delays.

11 total filings
· daily

Federal Professional Services Contracts — April 25, 2026

This digest covers one civilian federal professional services contract with a total obligation of $80,045,908 to SKYWARD DYNAMICS INFORMATION TECHNOLOGY, LLC from the Department of Health and Human Services' Centers for Medicare and Medicaid Services (CMS), representing 100% civilian exposure and 0% defense-related awards. The firm fixed price delivery order supports IT and telecom business applications for the Chronic Conditions Warehouse (CCW) and Virtual Research Data Center (VRDC), with a base + options ceiling of $140,432,595 and $36,076,503 already outlayed. The dominant agency and sector theme is HHS/CMS healthcare data IT systems under PSC DA01 and NAICS 541611. The highest-conviction signal is neutral (strength 3/10, materiality 2/10) due to the private LLC recipient's limited public investment linkage despite full and open competition. A key risk is high contract pricing risk under firm fixed price terms; watch options exercise decisions and outlay progress beyond $36M toward the 2027-04-29 (or potential 2029-04-29) end date.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — April 25, 2026

These four Federal IT & Cybersecurity contracts total $350,641,411 in obligations, all to civilian agencies (0/4 defense-related), highlighting steady revenue in VA, HHS, and DHS IT services. Dominant themes include DevSecOps support at VA and IT operations for HHS/NIH, with Veterans EZ Info Inc. securing the highest-conviction bullish signal via a $117M VA set-aside award offering multi-year visibility to 2030. Leidos Inc. captures two HHS contracts totaling $158.7M, reinforcing its civilian health IT position, though one is neutral due to advanced outlays nearing completion. Key risk is stagnant outlays on the aging $74.7M GDIT DHS contract ($0 outlayed since 2011), warranting monitoring for execution shortfalls.

4 total filings
· daily

All HHS Contracts — April 25, 2026

These four HHS contracts total $366,281,917 in obligations, entirely civilian with zero defense exposure, centered on NIH construction and IT services alongside CMS health data support. Dominant themes include multi-year revenue visibility for Hensel Phelps Construction Co ($127.6M NIH building construction) and Leidos, Inc. (combined $158.7M across two NIH IT awards), delivering the highest-conviction bullish signals amid neutral smaller plays. Full and open competition wins signal competitive positioning in civilian health infrastructure, but firm fixed-price structures across all awards introduce high execution risks. Key watch item: outlay progression on Hensel Phelps ($36.9M of $127.6M already spent) and remaining Leidos obligations.

4 total filings
· daily

Mega Contracts Monitor ($100M+) — April 25, 2026

These 5 mega contracts totaling $686,045,392 in obligations are 100% civilian (0/5 defense-related), underscoring sustained infrastructure and IT spending by DHS Coast Guard ($289.7M combined), GSA ($151.5M), HHS NIH ($127.6M), and VA ($117.3M). Dominant sector theme is construction (3/5 contracts: J.E. Dunn Construction $151.5M, Whiting-Turner $137.8M, Hensel Phelps $127.6M), signaling competitive wins in federal facility builds and clean-up under full and open competition. Highest-conviction bullish signal (strength 7-8/10 materiality) on multi-year revenue visibility for these firms through 2027-2029, with L3Harris ($151.9M aircraft mod) and Veterans EZ Info ($117.3M DevSecOps) adding diversification. Balanced by high firm-fixed-price execution risks across 4/5 contracts and low/zero outlays in 3/5 indicating early-stage funding. Key watch: outlay progress from current lows ($0-$36.9M) to validate revenue pacing.

5 total filings
· daily

High-Value Federal Grants ($5M+) — April 25, 2026

This digest covers 11 high-value federal grants totaling $1,160,990,335 in obligations, all civilian agency awards with 0 defense-related contracts, highlighting robust spending by DHS (Coast Guard), HHS (NIH/CMS), VA, and GSA. Dominant themes include construction for Coast Guard infrastructure recapitalization ($373.6M across L3Harris $151.9M, Whiting-Turner $137.8M, Birdon $83.9M) and federal facilities (J.E. Dunn $151.5M GSA FDA lab, Hensel Phelps $127.6M NIH), alongside IT/DevSecOps services to VA ($117.3M Veterans EZ Info) and HHS ($238.7M total Leidos and others). Highest-conviction bullish signal is multi-year construction revenue visibility for Whiting-Turner and J.E. Dunn through 2029 amid stable civilian funding. Key risk is pervasive high fixed-price execution risk across top awards, with low outlays signaling early-stage potential delays.

11 total filings
· daily

General Federal Contracts — April 25, 2026

This digest synthesizes 11 civilian federal contracts totaling $1,160,990,335 in obligations (0/11 defense-related), highlighting a civilian infrastructure and IT services theme dominated by DHS Coast Guard ($457.4M across four contracts) and HHS ($365.8M across four contracts). Highest-conviction bullish signals emerge from large construction awards to J.E. Dunn Construction Company ($151.5M GSA) and Whiting-Turner Contracting Company ($137.8M DHS Coast Guard), signaling multi-year revenue visibility through 2029 amid stable civilian agency spending. Leidos, Inc. captures two HHS IT contracts worth $158.7M combined, bolstering its civilian health IT exposure. Key risk is high fixed-price execution risk across top materiality contracts like L3Harris ($151.9M DHS) and Hensel Phelps ($127.6M HHS), with low outlays on newer awards vulnerable to spending delays.

11 total filings
· daily

Biotech Small-Cap Approvals — April 24, 2026

The FDA granted 4 'Other' approvals in the biotech small-cap stream for the period April 24 to April 24, 2026, comprising 0 NMEs, 0 biosimilars, 0 label expansions, and 4 others, all carrying neutral signals (strength and materiality 5/10). These include ANTHEA PHARMA's BUPIVACAINE HYDROCHLORIDE, ALKEM LABORATORIES LIMITED's TOLVAPTAN, LAURUS's VALSARTAN, and SANDOZ's ENZALUTAMIDE, each described as biosimilar FDA approvals despite the mix categorization. No dominant therapeutic area theme emerges, with products spanning anesthesia (BUPIVACAINE HYDROCHLORIDE), nephrology/cardiovascular (TOLVAPTAN, VALSARTAN), and oncology (ENZALUTAMIDE). The highest-conviction signal is SANDOZ's ENZALUTAMIDE approval, a neutral event implying modest commercial entry into a mature market with NOT_DISCLOSED peak sales and exclusivity. Key risk/watch item is the complete lack of disclosed commercial data (peak sales, exclusivity, pricing power, market position), raising execution uncertainty for these small-cap entrants.

4 total filings
· daily

Big Pharma Approvals — April 24, 2026

This week's Big Pharma approvals include 0 NMEs, 0 biosimilars, 0 label expansions, and 2 other approvals, delivering 2 bullish signals with no bearish or neutral outcomes. Regeneron Pharmaceuticals' label expansion for Dupilumab (Dupixent) provides a moderate bullish catalyst (strength 5/10, materiality 5/10), reinforcing its established franchise. The highest-conviction signal is Merck Sharp and Dohme LLC's NME approval for Doravirine and Islatravir (Idvynso™) (strength 8/10, materiality 8/10), highlighting strong pipeline execution despite 'other' categorization. No dominant therapeutic area theme emerges, as approvals span distinct profiles. Key risk/watch item: Lack of disclosed peak sales, exclusivity, pricing, and market position data warrants monitoring commercial traction post-approval.

2 total filings
· daily

New Drug Approvals (Original) — April 24, 2026

The FDA granted 5 approvals classified as Other during this period (0 NMEs, 0 biosimilars, 0 label expansions per official mix), consisting of 4 biosimilar approvals and 1 NME. These span diverse areas including anesthesia (BUPIVACAINE HYDROCHLORIDE), nephrology/cardiovascular (TOLVAPTAN, VALSARTAN), oncology (ENZALUTAMIDE), and HIV (DORAVIRINE AND ISLATRAVIR), with no dominant therapeutic area clustering. The highest-conviction bullish signal is MERCK SHARP AND DOHME LLC's NME approval for DORAVIRINE AND ISLATRAVIR (IDVYNSOTM), marking a first-in-class HIV therapy with 5-year NCE exclusivity and strong pipeline execution signal for Merck. Biosimilar approvals for ANTHEA PHARMA, ALKEM LABORATORIES LIMITED, LAURUS, and SANDOZ are neutral overall but carry dual implications: upside for entrants, downside risks for originators. Key risk/watch item: competitive revenue erosion for originators of these biosimilars (30-60% potential over 2-3 years).

5 total filings
· daily

Federal Construction & Infrastructure Contracts — April 24, 2026

A single $129,150,000 firm fixed-price contract was awarded to RECORD STEEL AND CONSTRUCTION, INC. by the Department of the Interior's National Park Service, representing 100% civilian exposure with zero defense-related obligations. The award supports rehabilitation of Canyon Village wastewater treatment systems in Yellowstone National Park under full and open competition, signaling sustained Interior/NPS spending on facilities maintenance amid a neutral overall signal (avg strength 3.0/10). Highest-conviction signal is the potential future revenue stream estimated at $71M annually over the 1.83-year performance period from 2026-04-22 to 2028-02-14, with no funds outlayed yet ($0). Key risk is high pricing risk inherent to the firm fixed-price structure; watch total outlayed progress and performance milestones toward the 2028-02-14 end date.

1 total filings